JOURNAL OF PRACTICAL HEPATOLOGY ›› 2015, Vol. 18 ›› Issue (3): 228-229.doi: 10.3969/j.issn.1672-5069.2015.02.002

• Orignal Article • Previous Articles     Next Articles

What’s the drawbacks of transarterial chemoembolization in treatment of patients with hepatocellular carcinoma

Tong Huan, Tang Chenghui   

  1. Department of Gastroenterology,West China Hospital,Sichuan University,Chengdu 610041
  • Received:2015-03-19 Online:2015-05-10 Published:2016-02-19

Key words: Hepatocellular carcinoma, Transarterial chemoembolization, Cyclooxygenase-2, Somatostatin, Ablation